Exposing GSK’s Unlawful Practices: A $3 Billion Whistleblowing Case Study
![](https://whistleblowerpartners.com/wp-content/uploads/2023/09/c8e00205-b1ae-4943-aca1-e3a74af2bd4a-1024x576.jpeg)
GlaxoSmithKline Case Study: Unveiling GSK’s Wrongdoings Costing the Company a $3 Billion Settlement GlaxoSmithKline, a major pharmaceutical player, had been under investigation for unlawful practices. Allegations included misleading drug promotion, failure to report safety data, and false price reporting. This initiated a comprehensive investigation, culminating in a legal battle to expose GSK’s misconduct and […]